| Pharmaceutical Information |
| Drug Name |
Benzylamphetamine |
| Drug ID |
BADD_D00249 |
| Description |
A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222) |
| Indications and Usage |
For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction |
| Marketing Status |
Not Available |
| ATC Code |
Not Available |
| DrugBank ID |
DB00865
|
| KEGG ID |
Not Available
|
| MeSH ID |
C015024
|
| PubChem ID |
10149140
|
| TTD Drug ID |
D0T5UL
|
| NDC Product Code |
Not Available |
| Synonyms |
benzylamphetamine | N-benzylamphetamine | desmethylbenzphetamine | benzylamphetamine, (-)-isomer | benzylamphetamine, (+)-isomer |
|
| Chemical Information |
| Molecular Formula |
C16H19N |
| CAS Registry Number |
156-08-1 |
| SMILES |
CC(CC1=CC=CC=C1)NCC2=CC=CC=C2 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
